X4 Pharmaceuticals Enters Oversold Territory
X4 Pharmaceuticals, Inc. XFOR has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at XFOR given that, according to its RSI reading of 27.92, it is now in oversold territory. […]